Structured evidence table for Bergamot Cholesterol Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Bergamot Cholesterol Randomized Trial | Data extraction focused on weight loss, body mass index, waist circumference, waist-to-hip ratio, and body fat percentage, and the risk of bias was assessed using the Revised Cochrane Risk-of-Bias Tool. | 1 | Pujia C (2026) | Effect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Bergamot Cholesterol Randomized Trial | This systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to assess the effect of nutraceuticals containing Citrus bergamia on the management of obesity in adults by assessing measures related to obesity. | 1 | Pujia C (2026) | Effect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Bergamot Cholesterol Randomized Trial | We searched the following databases until October 2024: PubMed, Web of Science, Scopus, and the Cochrane Central Register of Controlled Trials. | 1 | Pujia C (2026) | Effect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. |
| Bergamot Cholesterol Randomized Trial | 1 2 3 2 3 4 5 6 Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide, primarily driven by a combination of non-modifiable (gender and family history) and modifiable (e.g., dyslipidemia, hypertension, smoking, diabetes, and obesity) risk factors. | 3 | Carpenito Myriam (2025) | Unveiling the Power of Bergamot: Beyond Lipid-Lowering Effects |
| Bergamot Cholesterol Randomized Trial | Among modifiable risk factors, low-density lipoprotein cholesterol (LDL-C) is recognized as the most significant contributor to atherosclerosis [,,]. | 3 | Carpenito Myriam (2025) | Unveiling the Power of Bergamot: Beyond Lipid-Lowering Effects |
| Bergamot Cholesterol Randomized Trial | An undisputable body of evidence demonstrates a linear relationship between LDL-C and cardiovascular risk reduction []. | 3 | Carpenito Myriam (2025) | Unveiling the Power of Bergamot: Beyond Lipid-Lowering Effects |
Source documents